Commentary: Consensus Statement on Negative Symptoms
Open Access
- 12 October 2005
- journal article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 32 (2) , 223-224
- https://doi.org/10.1093/schbul/sbj010
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160???mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) studyInternational Clinical Psychopharmacology, 2002
- Low-Dose Neuroleptic Treatment of Outpatient SchizophrenicsArchives of General Psychiatry, 1983